A newly developed technology platform has the potential to treat diseases like diabetes, IBS, and obesity by using enteroendocrine (EE) cells found in human intestinal cells.
In a recent study, scientists sought to identify these gut keystone species and their functions with the goal of developing new disease treatments.
A recent study focusing on the gut microbiome may be a vital link to groundbreaking future treatment of gastrointestinal ailments such as irritable bowel syndrome, inflammatory bowel disease, and slow transit constipation.
Typical household chemicals affect the number of healthy microorganisms in the gut, according to a recent study.
Two new studies explore the idea that the bacteria strains in the microbiome must be studied to gain a greater understanding of the microbiome and gut health.